medigraphic.com
ISSN 1684-1824 (Electronic)

2019, Number 1

<< Back Next >>

Rev Méd Electrón 2019; 41 (1)

Glucocorticoid deprivation syndrome. Case presentation

Torres ÁA, Álvares EMC, Semper GAI, Torres ÁAY, Otero SG

Language: Spanish
References: 27
Page: 180-188
PDF size: 741.42 Kb.


ABSTRACT

The glucocorticoide deprivation symptom is the clinical symptom resulting from stoping the exogenous administration of steroids that were used for a long time, in spite of the administration way. It restrains the hypothalamus-pituitary-adrenal axis and therefore reduces corticotropine production and secretion. This is the case of a female patient, aged 54 years, with a continued steroid treatment. When stoping it, she began to lose weight and presented difficulties for walking. Besides orthostatic hypotension, she abruptly fell to the ground losing conciousness. She was carried to the hospital and there were not found periferal pulses nor arterial tension, a problem that was not solved by the active use of endovenous fluids. She kept on without regulating normal parameters, and was re-evaluated as a corticoid deprivation symptom and treated with prenisone. She gradually got better. The syndromes asociated to corticod deprivation begin due to the usage of high doses, or due to the abrupt withdrawal of a long corticotherapy. The whole of the symptoms appearing when corticoid withdrawal is not tolerated, in the absence of the underlying disease against which these medicines were indicated, and with a non-suppressed hypothalamus-pituitary-adrenal axis, is considered as a syndrome of corticoide withdrawal. In spite of its seriousness, of the frequency and importance of this secundary effect, sometimes it is not noticed; therefore it is essential to evaluate the indicated treatments and periodically reevaluate the treatments ordered for chronic diseases.


REFERENCES

  1. Díaz Socorro C, Turcios Tristá SE, Robles Torres E, García García Y. Síndrome de deprivación glucocorticoidea. Rev Cubana Endocrinol [Internet]. 2014 [citado 31/05/2017];25(3):198-205. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561- 29532014000300008&lng=es

  2. Barreira Mercado E. Corticoterapia en México y los esquemas terapéuticos. Rev Metab Óseo [Internet]. 2012 [citado 31/05/2017];10:13-20. Disponible en: http://www.imbiomed.com.mx/1/1/articulos.php?method=showDetail&id_revista=281 &id_seccion=4399&id_ejemplar=7930&id_articulo=80157

  3. Charmandari E, Kino T, Chrousos GP. Primary generalized familial and sporadic glucocorticoid resistance (Chrousos syndrome) and hypersensitivity. Endocr Dev. 2013;24:67-85. Citado en PubMed; PMID: 23392096.

  4. Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9(1):30. Citado en PubMed; PMID: 23947590.

  5. Strehl C, Buttgereit F. Optimized glucocorticoid therapy: teaching old drugs new tricks. Mol Cell Endocrinol. 2013;380(1-2):32-40. Citado en PubMed; PMID: 23403055.

  6. Lynnette KN, Kovacs W. Pharmacologic use of glucocorticoids [Internet]. Waltham (MA): Uptodate; 2016 [citado 23/05/2017]. Disponible en: https://www.uptodate.com/contents/glucocorticoid-withdrawal

  7. Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev. 2011;32:81–151. Citado en PubMed; PMID: 21051590.

  8. Furst DE, Saag KG. Glucocorticoid withdrawal [Internet]. Waltham (MA): UpToDate; 2016 [citado 23/05/2017]. Disponible en: https://www.uptodate.com/contents/glucocorticoid-withdrawal

  9. Kapadia CR, Nebesio TD, Myers SE, et al. Endocrine effects of inhaled corticosteroids in children. JAMA Pediatr. 2016;170(2):163-70. Citado en PubMed; PMID: 26720105.

  10. Luca F, Taquet MC, Goichot B. Secondary adrenal insufficiency due to exogenous glucocorticoid therapy. Rev Med Interne. 2013;34(5):324-7. Citado en PubMed; PMID: 23313326.

  11. Levin E, Gupta R, Butler D, et al. Topical steroid risk analysis: differentiating between physiologic and pathologic adrenal suppression. J Dermatolog Treat. 2014;25(6):501-6. Citado en PubMed; PMID: 24171390.

  12. Perdomo-Ramírez I, Linares-Ballesteros A, Acevedo Sedano L, et al. Supresión del eje hipotálamo-hipófisis-suprarrenal después de la quimioterapia de inducción en niños con leucemia linfoide aguda. Iatreia [Internet]. 2016 [citado 23/05/2017];29(1):18- 26. Disponible en: https://aprendeenlinea.udea.edu.co/revistas/index.php/iatreia/article/view/21059

  13. Aguirre MA, Luna M, Reyes Y, et al. Diagnóstico y manejo de la insuficiencia adrenal. Rev Venez Endocrinol Metab [Internet]. 2013 [citado 23/05/017];11(3):5-9. Disponible en: https://www.redalyc.org/articulo.oa?id=375540235007

  14. Nieman LK. Evaluation of the response to ACTH in adrenal insufficiency [Internet]. Waltham (MA): UpToDate; 2014 [citado 23/05/2017]. Disponible en: https://www.uptodate.com/contents/evaluation-of-the-response-to-acth-in-adrenalinsufficiency

  15. de Miguel Novoa P, Torres Vela E, Palacios García N, et al. Guía para el diagnóstico y tratamiento de la insuficiencia suprarrenal en el adulto. Endocrinol Nutr [Internet]. 2014 [citado 23/05/2017];61(Supl. 1):1-35. Disponible en: http://www.elsevier.es/esrevista- endocrinologia-nutricion-12-articulo-guia-el-diagnostico-tratamientoinsuficiencia- S1575092214735260

  16. Iliopoulou A, Abbas A, Murray R. How to manage withdrawal of glucocorticoid therapy. Prescriber [Internet]. 2013 [citado 23/05/2017];19:23-29. Disponible en: https://onlinelibrary.wiley.com/doi/pdf/10.1002/psb.1060

  17. Grossman A, Johannsson G, Quinkler M, et al. Perspectives on the management of adrenal insufficiency: clinical insights from across Europe. Eur J Endocrinol. 2013;169(6):R165-75. Citado en PubMed; PMID: 24031090.

  18. Falorni A, Minarelli V, Morelli S. Therapy of adrenal insuciency: an update. Endocrine [Internet]. 2013 [citado 23/05/2017];43(3):514–28. Disponible en: https://link.springer.com/article/10.1007/s12020-012-9835-4

  19. Mendoza Cruz AC, Wargon O, Adams S, et al. HypothalamicPituitary-Adrenal axis recovery following prolonged prednisolone therapy in infants. J Clin Endocrinol Metab. 2013;98(12):E1936-40. Citado en PubMed; PMID: 24081733.

  20. Duru N, van der Goes MC, Jacobs JW, Andrews T, et al. EULAR evidence-based and consensus-based recommendations on the management of medium to high dose glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis. 2013;72(12):1905-13. Citado en PubMed; PMID: 23873876.

  21. Kirwan J. What about prednisone? It might be the missing ingredient in the ACR Recommendations on the treatment of RA. The Rheumatologist [Internet]. 2013 [citado 23/05/2017];7:19. Disponible en: https://www.therheumatologist. org/article/prednisone-might-be-the-missing-ingredient-in-theamerican- college-of-rheumatologys-recommendations-for-treating-patients-withrheumatoid- arthritis/

  22. Saag KG. Short-term and long-term safety of glucocorticoids in rheumatoid arthritis. Bull NYU Hosp Jt Dis. 2012;70(Suppl 1):S21-5. Citado en PubMed; PMID: 23259654.

  23. Center SA, Randolph JF, Warner KL, et al. Influence of bodycondition on plasma prednisolone and prednisone concentrations in clinically healthy cats after single oral dose administration. Res Vet Sci. 2013;95(1):225-30. Citado en PubMed; PMID: 23473553.

  24. Quax RA, Manenschijn L, Koper JW, et al. Glucocorticoid sensitivity in health and disease. Rheum Dis Clin North Am. 2016;42(1):15-31. Citado en PubMed; PMID: 26611548.

  25. Pinho Silveiro S, Satler F. Rotinas em endocrinología [Internet]. Porto Alegre: Artmed; 2015 [citado 23/05/2017]. Disponible en: https://www.amazon.fr/Rotinasendocrinologia- Portuguese-Sandra-Silveiro-ebook/dp/B015HHJ48O

  26. Haller MC, Royuela A, Nagler EV, et al. Steroid avoidance or withdrawal for kidney transplant recipients. Cochrane Database Syst Rev. 2016;(8):CD005632. Citado en PubMed; PMID: 27546100.

  27. Dixon WG, Bansback N. Understanding the side effects on glucocorticoid therapy: shining a light on a drug everyone thinks they know. Ann Rheum Dis. 2012;71(11):1761-4. Citado en PubMed; PMID: 22851467.




2020     |     www.medigraphic.com